These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17907)

  • 21. [Preliminary results of a trial on the spirometric and associated effects of a new bronchodilator, C 325 (author's transl)].
    Minette A; Marcq M; Bruninx M
    Acta Tuberc Pneumol Belg; 1974; 65(5):520-33. PubMed ID: 4466343
    [No Abstract]   [Full Text] [Related]  

  • 22. [The bronchdilating action of reproterol in patients with bronchial asthma and chronic obstructive bronchitis (author's transl)].
    Tabori D; Conkic B; Todic V; Mijatovic M; Mirkovc S; Zecević D; Camprag D
    Arzneimittelforschung; 1977; 27(12):55-60. PubMed ID: 576833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New beta-adrenergic receptor stimulators in the symptomatic treatment of asthma and chronic obstructive bronchial diseases].
    Van Der Straeten M; Lamont H; Pauwels R; Tasson J
    Acta Tuberc Pneumol Belg; 1974; 65(3-4):384-94. PubMed ID: 4156900
    [No Abstract]   [Full Text] [Related]  

  • 24. The uses of simple spirometry.
    Sobol BJ; Emirgil C
    Ann Allergy; 1975 Jan; 34(1):34-40. PubMed ID: 1155819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Respiratory and circulatory investigations in obstructive and restrictive lung disease.
    Gabriel SK
    Acta Med Scand Suppl; 1972; 546():1-91. PubMed ID: 4518919
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparative studies on the oral therapy of obstructive respiratory tract diseases with clenbuterol, fenoterol and depot-orciprenaline (double-blind study)].
    Flohr E; Bischoff KO
    Verh Dtsch Ges Inn Med; 1978; (84):417-20. PubMed ID: 369198
    [No Abstract]   [Full Text] [Related]  

  • 27. The bronchodilator effects of orciprenaline and salbutamol: a double-blind study.
    Racoveanu C; Stanescu DC; Manicatide M; Stroescu V
    Bull Physiopathol Respir (Nancy); 1970; 6(4):809-18. PubMed ID: 4940888
    [No Abstract]   [Full Text] [Related]  

  • 28. [The relationships between the broncholytic and diuretic effects of theophylline in patients with obstructive lung diseases combined with oxalosis].
    Pospekhova GP; Kaiukov IG; Sinitsina TM; Razorenova TS
    Ter Arkh; 1997; 69(3):47-9. PubMed ID: 9229830
    [No Abstract]   [Full Text] [Related]  

  • 29. Isoetharine and salbutamol--a comparative bronchodilator trial.
    Chapman TT; De Wytt C
    J Ir Med Assoc; 1971 Mar; 64(407):137-40. PubMed ID: 4932017
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapeutic action of salbutamol as compared with orciprenaline in patients with chronic obstructive bronchopneumopathy. Double-blind study].
    Vesco R; Sussi GW
    Minerva Med; 1976 Apr; 67(17):1155-9. PubMed ID: 772479
    [No Abstract]   [Full Text] [Related]  

  • 31. [Chronic obstructive lung diseases in patients with ischemic heart disease: a 15-year study].
    Kozlova LI; Buzunov RV; Chuchalin AG
    Ter Arkh; 2001; 73(3):27-32. PubMed ID: 11417176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinico-functional evaluation of chronic obstructive lung diseases in association with hypertension].
    Soldatchenko SS; Kononenko IN; Rudieva NB; P'iankov AF
    Vrach Delo; 1991 Jun; (6):42-3. PubMed ID: 1891848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Action of bronchodilator agents on gaseous enchange in the lungs].
    Ciappi G; Orlandelli E; Valente S; Damato S; Pagliari G
    Recenti Prog Med; 1974 Jan; 56(1):77-92. PubMed ID: 4406416
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of stable chronic obstructive lung disease with inhaled corticosteroid].
    Vestbo J; Lange P
    Ugeskr Laeger; 2000 Jan; 162(4):520-3. PubMed ID: 10697457
    [No Abstract]   [Full Text] [Related]  

  • 35. A new bronchodilator, hexoprenaline, in obstructive pulmonary disease.
    van As A; Benjamin C; Stern JD
    Scand J Respir Dis; 1973; 54(1):28-37. PubMed ID: 4690403
    [No Abstract]   [Full Text] [Related]  

  • 36. [Heart rhythm changes in patients with chronic obstructive bronchopneumopathies: effects of different methylxanthine drugs].
    Cipri A; Pozzar F; Dini FL
    Minerva Cardioangiol; 1992; 40(1-2):31-9. PubMed ID: 1630668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Value of the MMEF/FEV1 index for the interpretation of spirographic data and the diagnosis of ventilatory disorders of the obstructive type].
    Szafrański W
    Pneumonol Pol; 1983 May; 51(5):265-75. PubMed ID: 6622270
    [No Abstract]   [Full Text] [Related]  

  • 38. [Importance of spasm and way of reactivity to bronchodilatator of patients with chronic obstructive pulmonary disease (author's transl)].
    Sprung J
    Plucne Bolesti Tuberk; 1981; 33(1):8-13. PubMed ID: 7244024
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparative studies on the effectiveness of inhalant beta 2 mimetics therapy in patients with obstructive respiratory disorders].
    Würtemberger G; Weil R; Schulte-Mönting J; Matthys H
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():304-6. PubMed ID: 2902608
    [No Abstract]   [Full Text] [Related]  

  • 40. [Chronic obstructive lung diseases and principles of their treatment].
    Pomerantsev VP; Kopalova SM; Maĭchuk EIu
    Klin Med (Mosk); 1985 Dec; 63(12):106-12. PubMed ID: 3912604
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.